MacroSOLV® - Drug Delivery Platform

Using our MacroSOLV® platform we apply our experience to the formulation of poorly soluble and poorly bioavailable drugs.

MacroSOLV uses a screening approach to bring lipid based formulation strategies to best effect to maximise the potential of your API.  Based on the skill and experience of Pharmaterials staff we can screen different formulation approaches rapidly and with minimal API requirements.

With many examples of successful outcomes from our MacroSOLV formulations having shown excellent bioavailability and having been through technology transfer, we are confident that we can help you.

MacroSOLV is a "fee for service" formulation development approach that does NOT have any license fees or milestone payments.  The technologies screened include:

• Suspension / Nanosuspension (Oral)
• Co-solvent Systems (Oral, Parenteral)
• Cyclodextrins (Oral, Parenteral, Topical)
• Oily liquids (Oral, Parenteral, Topical)
• Emulsions (Oral, Parenteral, Topical)
• Microemulsions (Oral, Topical)
• Mixed micelles (Parenteral)

The MacroSOLV approach gives you a rapid and reliable route to the best formulation approach for maximised bioavailability